Insider Buying: Microba Life Sciences Limited (ASX:MAP) Insider Acquires 200,000 Shares of Stock

Microba Life Sciences Limited (ASX:MAP) insider Ian Frazer acquired 200,000 shares of Microba Life Sciences stock in a transaction dated Thursday, November 14th. The shares were acquired at an average cost of A$0.17 ($0.11) per share, with a total value of A$33,600.00 ($21,960.78).

Microba Life Sciences Stock Performance

The company has a debt-to-equity ratio of 3.84, a current ratio of 2.61 and a quick ratio of 6.50.

About Microba Life Sciences

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development.